Atorvastatin Calcium Tablet
Product Images NDC 16571-137

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 16571-137). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 01)

Chemical structure of atorvastatin calcium, the active ingredient in Atorvastatin Calcium tablets by Rising Pharma Holdings, Inc. The diagram shows the molecular arrangement including calcium ions and hydration.*

FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 02)

A cumulative incidence line graph showing Atorvastatin versus Placebo over a period of 3.5 years. The graph illustrates two lines: a solid line for Atorvastatin and a dashed line for Placebo, with cumulative incidence (%) on the y-axis and time in years on the x-axis. The chart notes a hazard ratio (HR) of 0.64 and a p-value of 0.0005.*

FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 03)

A line graph comparing the cumulative hazard percentage over five years between placebo and atorvastatin groups. The x-axis represents time to first primary endpoint through four years of follow-up in years, and the y-axis shows cumulative hazard percentage. The graph includes hazard ratio (HR) and p-value statistics indicating a lower hazard with atorvastatin compared to placebo.*

FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 04)

A line graph comparing the time to first major cardiovascular endpoint over five years between subjects taking Atorvastatin 10 mg and 80 mg. The y-axis represents the percentage of subjects experiencing the event, with the 10 mg line slightly higher than the 80 mg line throughout the period.*

FDA Label Image

90 Tablets (3ce77d64 B08e 43b6 A3ab 3aca688f734a 05)

Label for Atorvastatin Calcium Tablets USP 10 mg oral tablets by Rising Pharma Holdings, Inc. The label states each film-coated tablet contains atorvastatin calcium equivalent to 10 mg atorvastatin. The package contains 90 tablets and specifies storage between 20° to 25°C, with manufacturing details of Graviti Pharmaceuticals Pvt. Ltd., India.*

FDA Label Image

90 Tablets (3ce77d64 B08e 43b6 A3ab 3aca688f734a 06)

Packaging label for Atorvastatin Calcium Tablets USP, 20 mg strength, containing 90 film-coated tablets. The label includes the Rising Pharma Holdings, Inc. logo and notes the product is Rx only. It states the active ingredient as atorvastatin calcium equivalent to 20 mg atorvastatin per tablet. Storage instructions specify 20° to 25°C. Manufacturer is Graviti Pharmaceuticals Pvt. Ltd., India, and distributor is Rising Pharma Holdings, Inc., East Brunswick, NJ.*

FDA Label Image

90 Tablets (3ce77d64 B08e 43b6 A3ab 3aca688f734a 07)

Label for Atorvastatin Calcium Tablets, USP 40 mg film-coated tablets, bottle of 90 tablets. Manufactured by Graviti Pharmaceuticals Pvt. Ltd., India, and distributed by Rising Pharma Holdings, Inc., East Brunswick, NJ. The label includes storage instructions (20° to 25°C) and a note that the product is prescription only.*

FDA Label Image

90 Tablets (3ce77d64 B08e 43b6 A3ab 3aca688f734a 08)

Atorvastatin Calcium Tablets USP 80 mg film-coated oral tablets, packaged in a 90-tablet container. The label shows Rising Pharmaceuticals as the labeler and states it is Rx only. The manufacturer is Graviti Pharmaceuticals Pvt. Ltd., Telangana, India. Storage instructions and dosage guidance reference are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.